Unaudited Condensed Consolidated Statements of Cash Flows (USD $) | | |
In Thousands | 9 Months Ended
Mar. 31, 2010
| 9 Months Ended
Mar. 31, 2009
|
Operating activities: | | |
Net income (loss) | $2,826 | ($8,688) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | | |
Amortization of intangible assets | 9,949 | 11,973 |
Stock compensation expense | 6,669 | 6,298 |
Depreciation and amortization of property and equipment | 3,364 | 2,950 |
Deferred income tax provision | 462 | 196 |
Provision for allowances on accounts receivable | (99) | (6) |
Provision for obsolete inventory | 2 | 12 |
Excess tax benefits associated with stock compensation | (162) | (12) |
(Gain) loss on foreign exchange | (78) | 246 |
Loss on disposal of equipment | 4 | 13 |
Changes in operating assets and liabilities: | | |
Accounts receivable | (2,420) | 2,418 |
Inventory, prepaid expenses and other assets | (676) | (1,759) |
Accounts payable, accrued expenses and other liabilities | (1,150) | (5,100) |
Deferred revenue | (552) | 9,291 |
Net cash provided by operating activities | 18,139 | 17,832 |
Investing activities: | | |
Acquisition of assets and businesses | (17,817) | 0 |
Purchases of held-to-maturity securities | (50) | (53) |
Proceeds from sales of held-to-maturity securities | 50 | 53 |
Purchases of property and equipment | (3,064) | (2,477) |
Net cash used in investing activities | (20,881) | (2,477) |
Financing activities: | | |
Proceeds from exercise of stock options and employee stock purchase plan | 12,278 | 1,327 |
Repurchase of common stock | (23) | (3,068) |
Excess tax benefits associated with stock compensation | 162 | 12 |
Capital lease payments | (84) | (97) |
Payment of long-term financing obligation | 0 | (89) |
Payment of bank financing fees | (13) | (20) |
Net cash provided by (used in) financing activities | 12,320 | (1,935) |
Effect of exchange rate changes on cash and cash equivalents | (1,604) | (7,779) |
Increase in cash and cash equivalents | 7,974 | 5,641 |
Cash and cash equivalents at beginning of period | 50,255 | 35,316 |
Cash and cash equivalents at end of period | 58,229 | 40,957 |
Supplemental disclosure of cash flow information: | | |
Issuance of warrants in connection with acquisition of business | $10,520 | $0 |